Local view for "http://purl.org/linkedpolitics/eu/plenary/2004-01-13-Speech-2-319"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20040113.14.2-319"2
lpv:hasSubsequent
lpv:speaker
lpv:spokenAs
lpv:translated text
"Madam President, today, like any other day, more than 8 000 people have died of AIDS for lack of treatment. In Africa, more than 4 million AIDS sufferers are in desperate need of treatment and only 50 000 people have access to it. Moreover, AIDS is not the only scourge overwhelming the countries of the South: tuberculosis is on the increase and kills 2 million people every year; malaria is responsible for between 1 and 2 million deaths every year and affects between 300 and 500 million people. In fact, we have the means to cure these diseases or to significantly reduce the death rate. But the treatment is expensive, too expensive for countries that can only afford to spend derisory sums on their health services, with the result that medicines are for the North and coffins for the South. Fortunately, things are starting to change. Much progress was made in 2003, giving cause for a glimmer of hope: the WHO initiative to provide treatment for 3 million sufferers by 2005; the agreement reached on 30 August 2003 in Geneva by the members of the WHO; the decision of the South African Government to launch a national treatment programme; the efforts to bring down the price of antiretroviral drugs on the world market and the programme of clinical trials in a partnership between Europe and the developing countries, with a budget of EUR 600 million. These initiatives are very encouraging, but they are still far from being enough. The Union itself is being slow to deliver on its financial promises and the Sandbæk report is a timely reminder to the European Union to firm up its commitments, setting it a target that is appropriate to what is at stake. It reminds us that the absolute priority has to be access to medicines for all sufferers, in accordance with the Doha Declaration. The existence of patents should not therefore constitute a barrier to the manufacture or purchase of vital medicines. Furthermore, the report forcibly underlines the fact that the prevention and treatment of transmissible diseases are the concern of everyone, because they constitute a global public good. It sets an ambitious target for the financial contribution of the European Union and its Member States, a target of a billion euros a year. In adopting this report, Europe will reaffirm that it intends to play an important role in the fight against these dreadful diseases."@en1

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph